Loxo Oncology Inc (LOXO.OQ)
LOXO.OQ on NASDAQ Stock Exchange Global Market
135.00USD
7 Dec 2018
135.00USD
7 Dec 2018
Change (% chg)
$-0.17 (-0.13%)
$-0.17 (-0.13%)
Prev Close
$135.17
$135.17
Open
$134.25
$134.25
Day's High
$137.38
$137.38
Day's Low
$132.26
$132.26
Volume
144,270
144,270
Avg. Vol
110,778
110,778
52-wk High
$208.78
$208.78
52-wk Low
$75.87
$75.87
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 42.47 | -0.887 |
| Jun '18 | 42.60 | -0.389 | |
| Mar '18 | 38.43 | -0.119 | |
| FY 2017 | Dec '17 | 21.30 | -0.688 |
| Sep '17 | 0.00 | -2.454 | |
| Jun '17 | 0.00 | -1.143 | |
| Mar '17 | 0.00 | -0.956 | |
| FY 2016 | Dec '16 | 0.00 | -1.260 |
| Sep '16 | 0.00 | -0.819 | |
| Jun '16 | 0.00 | -0.773 | |
| Mar '16 | 0.00 | -0.593 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 10 | 58.58 | 99.25 | 45.40 | 23.59 |
| Quarter Ending Mar-19 | 5 | 50.48 | 75.40 | 30.70 | 13.62 |
| Year Ending Dec-18 | 11 | 178.32 | 224.00 | 139.37 | 31.34 |
| Year Ending Dec-19 | 9 | 174.39 | 396.90 | 15.60 | 97.47 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 11 | -0.81 | -0.04 | -1.23 | -0.84 |
| Quarter Ending Mar-19 | 6 | -0.70 | -0.06 | -1.71 | -0.83 |
| Year Ending Dec-18 | 10 | -2.16 | -1.43 | -2.60 | -5.04 |
| Year Ending Dec-19 | 10 | -3.26 | 3.20 | -9.08 | -4.42 |
| LT Growth Rate (%) | 1 | 37.00 | 37.00 | 37.00 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 92.25 | 33.63 | |
| P/E High - Last 5 Yrs. | -- | 323.36 | 45.43 | |
| P/E Low - Last 5 Yrs. | -- | 90.29 | 24.43 | |
| Beta | -- | 0.91 | 0.90 | |
| Price to Sales (TTM) | -- | 116.41 | 5.77 | |
| Price to Book (MRQ) | 5.67 | 15.60 | 5.12 | |
| Price to Tangible Book (MRQ) | 5.67 | 14.89 | 6.54 | |
| Price to Cash Flow (TTM) | -- | 72.75 | 23.57 | |
| % Owned Institutions | -- | 12.59 | 1.83 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.39 | 1.49 | |
| Dividend Yield - 5 Year Avg | -- | 0.31 | 1.50 | |
| Dividend 5 Year Growth Rate | -- | 2.65 | 5.08 | |
| Payout Ratio(TTM) | -- | 23.68 | 43.75 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 358.89 | 7.43 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 90.38 | 5.80 | |
| Sales - 5 Yr. Growth Rate | -- | 31.32 | 10.19 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -47.91 | 36.71 | 21.03 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -60.01 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 39.68 | 10.79 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 39.59 | 15.12 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.98 | 2.28 |
| Current Ratio (MRQ) | 42.15 | 5.42 | 3.11 |
| LT Debt to Equity (MRQ) | 0.00 | 33.58 | 11.47 |
| Total Debt to Equity (MRQ) | 0.00 | 35.41 | 15.63 |
| Interest Coverage (TTM) | -- | -152.89 | 31.38 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 41.87 | 54.21 | |
| Gross Margin - 5 Yr. Avg. | -- | 49.14 | 51.98 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -506.71 | 11.83 | |
| Operating Margin (TTM) | -- | -728.63 | 4.90 | |
| Operating Margin - 5 Yr. Avg. | -- | -526.19 | 7.44 | |
| Pre-Tax Margin (TTM) | -- | -694.90 | 5.91 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -531.06 | 7.89 | |
| Net Profit Margin (TTM) | -- | -696.67 | 2.16 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -534.50 | 4.12 | |
| Effective Tax Rate (TTM) | -- | 25.12 | 23.36 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 20.63 | 24.15 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 0 | 25,687,363 | 898,926,015 | |
| Net Income/Employee (TTM) | -3,441,862 | 2,194,067 | 106,550,787 | |
| Receivable Turnover (TTM) | -- | 18.46 | 5.94 | |
| Inventory Turnover (TTM) | -- | 2.61 | 3.62 | |
| Asset Turnover (TTM) | 0.00 | 0.43 | 0.97 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -30.82 | -1.11 | 11.50 | |
| Return on Assets - 5 Yr. Avg. | -- | 2.88 | 12.67 | |
| Return on Investment (TTM) | -31.65 | 0.28 | 15.02 | |
| Return on Investment - 5 Yr. Avg. | -- | 1.84 | 16.45 | |
| Return on Equity (TTM) | -31.65 | 0.94 | 16.60 | |
| Return on Equity - 5 Yr. Avg. | -- | 2.30 | 17.56 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | -63.08 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Loxo Oncology Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 14.65 | 10.70 | 76 | 57 |
| 13 Week | 14.21 | 8.65 | 69 | 62 |
| 26 Week | 83.39 | 69.45 | 90 | 81 |
| 52 Week | 280.96 | 222.90 | 97 | 47 |
| YTD | 172.96 | 139.71 | 93 | 60 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 99.42% |
| # of Holders: | 326 |
| Total Shares Held: | 30,437,830 |
| 3 Mo. Net Change: | -298,413 |
| # New Positions: | 42 |
| # Closed Positions: | 27 |
| # Increased Positions: | 167 |
| # Reduced Positions: | 118 |
| # Net Buyers: | 49 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.